Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
|---|---|---|---|---|---|---|---|
| Synthetic Biologics Inc. | -5.070% | -1.580% | -8.017% | -74.503% | -45.500% | -95.514% | -95.880% |
| Viracta Therapeutics Inc. | -2.250% | -14.902% | -16.538% | -64.715% | -12.146% | -95.762% | -97.846% |
| Evoke Pharma Inc. | 6.120% | 12.554% | 21.495% | -63.889% | -44.974% | -95.935% | -92.521% |
| Seres Therapeutics Inc | 1.790% | 8.237% | -28.257% | -82.662% | -42.824% | -96.072% | - |
| Nordic Nanovector ASA | -0.510% | -1.005% | -1.005% | -52.126% | -27.172% | -96.255% | -97.809% |
| Fate Therapeutics Inc. | -0.510% | -4.840% | -15.750% | -35.074% | -18.166% | -96.277% | - |
| Acelrx Pharmaceuticals Inc. | -2.390% | -0.969% | -10.209% | -21.195% | 15.537% | -96.312% | -98.048% |
| Gensight Biologics SA | -0.340% | -7.006% | -19.780% | -57.925% | -34.086% | -96.366% | -79.694% |
| TALI Digital Ltd. | - | 0.000% | 0.000% | -50.000% | 0.000% | -96.429% | -82.143% |
| NeuroVive Pharmaceutical AB | -5.000% | -63.462% | -67.797% | -84.921% | -84.553% | -96.607% | -98.123% |
| Bluebird Bio Inc. | 0.260% | -6.079% | -1.767% | -72.135% | -31.328% | -96.776% | - |
| TherapeuticsMD Inc. | -4.000% | -7.692% | -25.773% | -62.304% | -31.429% | -96.852% | -98.780% |
| Synairgen plc | 14.710% | 24.468% | -23.026% | -32.604% | -9.861% | -96.916% | -39.063% |
| Sangamo Therapeutics Inc. | -6.010% | -13.928% | -44.508% | -75.121% | -47.992% | -96.969% | -97.081% |
| Fibrogen Inc. | -0.600% | -29.697% | -36.077% | -74.615% | -21.893% | -97.050% | -98.329% |
| CytoTools AG | -15.550% | -4.583% | -11.923% | -77.549% | -40.519% | -97.064% | -95.510% |
| Anges MG Inc | - | -4.854% | -7.547% | -68.889% | -51.000% | -97.074% | -96.475% |
| Kala Pharmaceuticals Inc. | -0.500% | -1.803% | -0.910% | -53.816% | -8.129% | -97.168% | - |
| Quantum Genomics S.A. | 2.210% | -5.714% | -10.465% | -42.963% | 5.000% | -97.649% | - |
| Oncopeptides AB | -1.770% | -10.656% | -28.642% | -70.186% | -68.651% | -97.673% | - |
| Cara Therapeutics Inc. | -9.980% | - | -58.355% | -90.409% | -63.490% | -98.022% | -98.726% |
| Hybrigenics S.A. | 3.130% | -2.941% | -77.852% | -93.592% | -82.540% | -98.084% | -96.118% |
| Qualigen Therapeutics Inc. | -8.000% | 59.036% | 21.101% | -69.690% | -47.305% | -98.394% | - |
| Forte Biosciences Inc. | -5.020% | -5.417% | -14.340% | -50.110% | -29.612% | -98.424% | - |
| Carisma Therapeutics Inc. | -6.830% | -25.662% | -2.112% | -86.245% | -61.095% | -98.619% | -98.156% |